Mathew D Rand

Title: Mathew D Rand: Innovator in Blood Coagulation Inhibition

Introduction

Mathew D Rand is a notable inventor based in Danvers, MA (US). He has made significant contributions to the field of blood coagulation, holding 2 patents that focus on innovative methods for inhibiting blood clotting. His work is particularly relevant in medical and research settings, where the management of blood coagulation is critical.

Latest Patents

Rand's latest patents revolve around the inhibition of coagulation in blood and blood products. The present invention provides methods for inhibiting blood clotting by adding corn trypsin inhibitor (CTI) to blood or a blood product in an amount sufficient to inhibit the clotting. The CTI can be utilized alone or in combination with other anti-coagulants. One aspect of the invention features plasma clotting assays that exhibit substantially prolonged clotting times. Additionally, clotting assays using whole or minimally altered blood are also provided. The invention further includes methods for storing blood or blood products at low temperatures with the CTI.

Career Highlights

Mathew D Rand is affiliated with the University of Vermont and State Agricultural College, where he continues to contribute to research and innovation in his field. His work has implications for both clinical practices and research methodologies in blood management.

Collaborations

Rand has collaborated with notable colleagues, including Kenneth G Mann and Kevin M Cawthern, who share his commitment to advancing the understanding and management of blood coagulation.

Conclusion

Mathew D Rand's innovative approaches to inhibiting blood coagulation highlight his significant role in medical research. His patents reflect a dedication to improving blood management techniques, which can have a profound impact on patient care and clinical outcomes.